Riskpilot← Back to searchSign inGet full accessVÅGEN SPESIALISTSENTER AS
ASActiveOrg 913837533Strandkaien 16, 5013 BergenMedical specialists activities · NACE 8622Est. 20141 employees
Revenue 2024
NOK 2,1M
+3% vs 2023
EBITDA margin
-1.9%
-211% vs 2023
Equity ratio
3.8%
Financial strength
Net profit 2024
NOK -48K
-296% vs 2023
| Revenue | NOK 2,1M | +3% |
| EBITDA | NOK -39K | -211% |
| Net profit | NOK -48K | -296% |
| Total assets | NOK 493K | -25% |
| Equity | NOK 19K | -72% |
| Employees | 1 | — |
Legal name
VÅGEN SPESIALISTSENTER AS
Org number
913837533
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
2. juli 2014
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder eller nestleder hver for seg, eller to styremedlemmer i fellesskap.
Company purpose
Tilrettelegge virksomhet og fordele kostnader for legespesialister med kontorfellesskap og som leier lokaler av strandkaien eiendom as.
Address
Strandkaien 16, 5013 Bergen
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 659 | 2 274 | 2 182 | 2 023 | 2 079 |
| Staff expenses | −1 566 | −899 | −948 | −807 | −807 |
| EBITDA | −71 | 238 | 16 | 35 | −39 |
| Depreciation & amort. | −86 | −20 | −5 | −12 | −12 |
| EBIT | −157 | 218 | 11 | 23 | −51 |
| Net financials | 1 | 0 | 0 | 2 | 2 |
| Profit before tax | −156 | 218 | 11 | 25 | −48 |
| Tax | −0 | 0 | −0 | 0 | −0 |
| Net profit | −156 | 218 | 11 | 25 | −48 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 505 | 636 | 382 | 659 | 493 |
| Equity | 89 | 31 | 42 | 67 | 19 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 417 | 605 | 340 | 592 | 474 |
| Total debt | 417 | 605 | 340 | 592 | 474 |
EBITDA margin
-1.9%
This company
15.8%
Market median
-112% vs market
20202024
Equity ratio
3.8%
This company
38.2%
Market median
-90% vs market
20202024
Return on equity
-258.5%
This company
18.4%
Market median
-1505% vs market
20202024
Net profit margin
-2.3%
This company
8.1%
Market median
-128% vs market
20202024
Asset turnover
4.22×
This company
1.12×
Market median
+277% vs market
20202024
Debt / equity
25.45×
This company
0.62×
Market median
-4005% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2025 | |
| Deputy Chairman | 2025 | |
| Board of Directors | 2014 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 | |
| Individual | 20% | 20% | 2022 | |
| Individual | 16.67% | 16.67% | 2022 | |
| Individual | 3.33% | 3.33% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VÅGEN SPESIALISTSENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Usman Afzal | Board of Directors | 0 companies |
| Kenneth Kjøde Sandviknes | Deputy Chairman | 0 companies |
| Kenneth Michael Brattetveit | Board of Directors | 0 companies |